The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase II study of arsenic trioxide and temozolomide in combination with radiation therapy in patients with malignant gliomas.
Priya Kumthekar
No relevant relationships to disclose
Sean Aaron Grimm
No relevant relationships to disclose
MaryAnne H. Marymont
No relevant relationships to disclose
Minesh P. Mehta
No relevant relationships to disclose
James Chandler
No relevant relationships to disclose
Kenji Muro
No relevant relationships to disclose
Borko Jovanovic
No relevant relationships to disclose
Irene B. Helenowski
No relevant relationships to disclose
Katie McCarthy
No relevant relationships to disclose
Jeffrey J. Raizer
Research Funding - Cephalon